Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novobac is a biotechnology company specializing in the research, development, and commercialization of high-performance microbial strains and probiotic solutions. The company leverages a proprietary microbial screening and fermentation platform to develop functional ingredients for the healthcare, nutrition, and animal health sectors. Their work focuses on optimizing the gut microbiota to address various gastrointestinal and metabolic health challenges. Novobac provides both standardized probiotic strains and customized microbial formulations for global partners. By integrating advanced genomic analysis with large-scale production capabilities, the company aims to deliver science-backed microbial products that improve human and animal well-being.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novobac.